Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial of a vaccine therapy for recurrent stage III/IV melanoma not removable by surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaccine therapy

Snippet

Sponsor: Ahmad Tarhini | Conditions: Intraocular Melanoma, Malignant Conjunctival Neoplasm | Phase 1 | Status: COMPLETED